Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 238

1.

Extent of resection and survival for oligodendroglioma: a U.S. population-based study.

Kinslow CJ, Garton ALA, Rae AI, Marcus LP, Adams CM, McKhann GM, Sisti MB, Connolly ES, Bruce JN, Neugut AI, Sonabend AM, Canoll P, Cheng SK, Wang TJC.

J Neurooncol. 2019 Sep;144(3):591-601. doi: 10.1007/s11060-019-03261-5. Epub 2019 Aug 12.

PMID:
31407129
2.

Frameless Stereotactic Radiosurgery on the Gamma Knife Icon: Early Experience From 100 Patients.

Vulpe H, Save AV, Xu Y, Elliston CD, Garrett MD, Wu CC, Cheng SK, Jani AH, Bruce JN, McKhann GM, Wang TJC, Sisti MB.

Neurosurgery. 2019 Aug 2. pii: nyz227. doi: 10.1093/neuros/nyz227. [Epub ahead of print]

PMID:
31375826
3.

Validation of an effective implantable pump-infusion system for chronic convection-enhanced delivery of intracerebral topotecan in a large animal model.

D'Amico RS, Neira JA, Yun J, Alexiades NG, Banu M, Englander ZK, Kennedy BC, Ung TH, Rothrock RJ, Romanov A, Guo X, Zhao B, Sonabend AM, Canoll P, Bruce JN.

J Neurosurg. 2019 Aug 2:1-10. doi: 10.3171/2019.3.JNS1963. [Epub ahead of print]

PMID:
31374547
4.

Plasma Agouti-Related Protein Levels in Acromegaly and Effects of Surgical or Pegvisomant Therapy.

Freda PU, Reyes-Vidal C, Jin Z, Pugh M, Panigrahi SK, Bruce JN, Wardlaw SL.

J Clin Endocrinol Metab. 2019 Nov 1;104(11):5453-5461. doi: 10.1210/jc.2019-01079.

PMID:
31361303
5.

Spinal location is prognostic of survival for solitary-fibrous tumor/hemangiopericytoma of the central nervous system.

Boyett D, Kinslow CJ, Bruce SS, Sonabend AM, Rae AI, McKhann GM, Sisti MB, Bruce JN, Cheng SK, Wang TJC.

J Neurooncol. 2019 Jul;143(3):457-464. doi: 10.1007/s11060-019-03177-0. Epub 2019 May 3.

PMID:
31054100
6.

Author Correction: Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma.

Zhao J, Chen AX, Gartrell RD, Silverman AM, Aparicio L, Chu T, Bordbar D, Shan D, Samanamud J, Mahajan A, Filip I, Orenbuch R, Goetz M, Yamaguchi JT, Cloney M, Horbinski C, Lukas RV, Raizer J, Rae AI, Yuan J, Canoll P, Bruce JN, Saenger YM, Sims P, Iwamoto FM, Sonabend AM, Rabadan R.

Nat Med. 2019 Jun;25(6):1022. doi: 10.1038/s41591-019-0449-8.

PMID:
30996326
7.

Natural history, clinical course and predictors of interval time from initial diagnosis to development of subsequent NSCLC brain metastases.

Smith DR, Bian Y, Wu CC, Saraf A, Tai CH, Nanda T, Yaeh A, Lapa ME, Andrews JIS, Cheng SK, McKhann GM, Sisti MB, Bruce JN, Wang TJC.

J Neurooncol. 2019 May;143(1):145-155. doi: 10.1007/s11060-019-03149-4. Epub 2019 Mar 14.

PMID:
30874953
8.

De novo gene signature identification from single-cell RNA-seq with hierarchical Poisson factorization.

Levitin HM, Yuan J, Cheng YL, Ruiz FJ, Bush EC, Bruce JN, Canoll P, Iavarone A, Lasorella A, Blei DM, Sims PA.

Mol Syst Biol. 2019 Feb 22;15(2):e8557. doi: 10.15252/msb.20188557.

9.

Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma.

Zhao J, Chen AX, Gartrell RD, Silverman AM, Aparicio L, Chu T, Bordbar D, Shan D, Samanamud J, Mahajan A, Filip I, Orenbuch R, Goetz M, Yamaguchi JT, Cloney M, Horbinski C, Lukas RV, Raizer J, Rae AI, Yuan J, Canoll P, Bruce JN, Saenger YM, Sims P, Iwamoto FM, Sonabend AM, Rabadan R.

Nat Med. 2019 Mar;25(3):462-469. doi: 10.1038/s41591-019-0349-y. Epub 2019 Feb 11. Erratum in: Nat Med. 2019 Apr 17;:.

PMID:
30742119
10.

Plasma Agouti-Related Protein and Cortisol Levels in Cushing Disease: Evidence for the Regulation of Agouti-Related Protein by Glucocorticoids in Humans.

Page-Wilson G, Peters JB, Panigrahi SK, Jacobs TP, Korner J, Otten M, Bruce JN, Wardlaw SL.

J Clin Endocrinol Metab. 2019 Mar 1;104(3):961-969. doi: 10.1210/jc.2018-01909.

PMID:
30597030
11.

Monitoring Radiation Treatment Effects in Glioblastoma: FLAIR Volume as Significant Predictor of Survival.

Garrett MD, Yanagihara TK, Yeh R, McKhann GM, Sisti MB, Bruce JN, Sheth SA, Sonabend AM, Wang TJC.

Tomography. 2017 Sep;3(3):131-137. doi: 10.18383/j.tom.2017.00009.

12.

Single-cell transcriptome analysis of lineage diversity in high-grade glioma.

Yuan J, Levitin HM, Frattini V, Bush EC, Boyett DM, Samanamud J, Ceccarelli M, Dovas A, Zanazzi G, Canoll P, Bruce JN, Lasorella A, Iavarone A, Sims PA.

Genome Med. 2018 Jul 24;10(1):57. doi: 10.1186/s13073-018-0567-9.

13.

Pineal region glioblastomas display features of diffuse midline and non-midline gliomas.

D'Amico RS, Zanazzi G, Wu P, Canoll P, Bruce JN.

J Neurooncol. 2018 Oct;140(1):63-73. doi: 10.1007/s11060-018-2931-4. Epub 2018 Jul 10.

PMID:
29992434
14.

Effectiveness of perioperative antiepileptic drug prophylaxis for early and late seizures following oncologic neurosurgery: a meta-analysis.

Joiner EF, Youngerman BE, Hudson TS, Yang J, Welch MR, McKhann GM, Neugut AI, Bruce JN.

J Neurosurg. 2018 Apr 1:1-9. doi: 10.3171/2017.10.JNS172236. [Epub ahead of print] Review.

PMID:
29701546
15.

Craniotomy and Survival for Primary Central Nervous System Lymphoma.

Rae AI, Mehta A, Cloney M, Kinslow CJ, Wang TJC, Bhagat G, Canoll PD, Zanazzi GJ, Sisti MB, Sheth SA, Connolly ES, McKhann GM, Bruce JN, Iwamoto FM, Sonabend AM.

Neurosurgery. 2019 Apr 1;84(4):935-944. doi: 10.1093/neuros/nyy096.

PMID:
29660011
16.

The Annual Neurosurgery Charity Softball Tournament: 15th Anniversary Commemorative Article. The creation, development, and establishment of a neurosurgical tradition.

Komotar RJ, Goldstein HE, Bruce JN.

J Neurosurg. 2018 Jun;128(6):1605-1611. doi: 10.3171/2018.1.JNS172893. Epub 2018 Feb 23. No abstract available.

PMID:
29473774
17.

Solitary-fibrous tumor/hemangiopericytoma of the central nervous system: a population-based study.

Kinslow CJ, Bruce SS, Rae AI, Sheth SA, McKhann GM, Sisti MB, Bruce JN, Sonabend AM, Wang TJC.

J Neurooncol. 2018 May;138(1):173-182. doi: 10.1007/s11060-018-2787-7. Epub 2018 Feb 9.

PMID:
29427152
18.

Single institution validation of a modified graded prognostic assessment of patients with breast cancer brain metastases.

Tai CH, Wu CC, Hwang ME, Saraf A, Grubb C, Jani A, Lapa ME, Andrews JIS, Isaacson SR, Sonabend AM, Sheth SA, McKhann GM, Sisti MB, Bruce JN, Cheng SK, Connolly EP, Wang TJ.

CNS Oncol. 2018 Jan;7(1):25-34. doi: 10.2217/cns-2017-0023. Epub 2018 Feb 2.

19.

Local Glioma Cells Are Associated with Vascular Dysregulation.

Bowden SG, Gill BJA, Englander ZK, Horenstein CI, Zanazzi G, Chang PD, Samanamud J, Lignelli A, Bruce JN, Canoll P, Grinband J.

AJNR Am J Neuroradiol. 2018 Mar;39(3):507-514. doi: 10.3174/ajnr.A5526. Epub 2018 Jan 25.

20.

Extent of BOLD Vascular Dysregulation Is Greater in Diffuse Gliomas without Isocitrate Dehydrogenase 1 R132H Mutation.

Englander ZK, Horenstein CI, Bowden SG, Chow DS, Otten ML, Lignelli A, Bruce JN, Canoll P, Grinband J.

Radiology. 2018 Jun;287(3):965-972. doi: 10.1148/radiol.2017170790. Epub 2018 Jan 24.

PMID:
29369751
21.

Capturing Quality: The Challenge for High-Volume Academic Medical Centers.

Youngerman BE, Bruce JN.

Mayo Clin Proc. 2018 Jan;93(1):4-6. doi: 10.1016/j.mayocp.2017.11.010. No abstract available.

PMID:
29304920
22.

Clinical and molecular characteristics of gliosarcoma and modern prognostic significance relative to conventional glioblastoma.

Smith DR, Wu CC, Saadatmand HJ, Isaacson SR, Cheng SK, Sisti MB, Bruce JN, Sheth SA, Lassman AB, Iwamoto FM, Wang SH, Canoll P, McKhann GM 2nd, Wang TJC.

J Neurooncol. 2018 Apr;137(2):303-311. doi: 10.1007/s11060-017-2718-z. Epub 2017 Dec 20.

PMID:
29264835
23.

Local control and overall survival for adjuvant stereotactic radiosurgery in patients with residual or recurrent disease.

Nanda T, Yaeh A, Wu CC, Jani A, Saad S, Qureshi YH, Cauley KA, Lesser J, Cheng SK, Isaacson SR, Sisti MB, Bruce JN, McKhann GM, Sheth SA, Lassman AB, Wang TJC.

J Neurooncol. 2018 Jan;136(2):281-287. doi: 10.1007/s11060-017-2651-1. Epub 2017 Nov 23.

PMID:
29170908
24.

The modified frailty index and 30-day adverse events in oncologic neurosurgery.

Youngerman BE, Neugut AI, Yang J, Hershman DL, Wright JD, Bruce JN.

J Neurooncol. 2018 Jan;136(1):197-206. doi: 10.1007/s11060-017-2644-0. Epub 2017 Nov 14.

PMID:
29139096
25.

Induction of synthetic lethality in IDH1-mutated gliomas through inhibition of Bcl-xL.

Karpel-Massler G, Ishida CT, Bianchetti E, Zhang Y, Shu C, Tsujiuchi T, Banu MA, Garcia F, Roth KA, Bruce JN, Canoll P, Siegelin MD.

Nat Commun. 2017 Oct 20;8(1):1067. doi: 10.1038/s41467-017-00984-9.

26.

Letter: Surgical Decision Making From Image-Based Biophysical Modeling of Glioblastoma: Not Ready for Primetime.

Massey SC, Johnston SK, Canoll PD, Bruce JN, Bendok BR, Swanson KR.

Neurosurgery. 2018 Jan 1;82(1):E17-E18. doi: 10.1093/neuros/nyx481. No abstract available.

PMID:
29029349
27.

Failure to Rescue and Mortality Following Resection of Intracranial Neoplasms.

Malone H, Cloney M, Yang J, Hershman DL, Wright JD, Neugut AI, Bruce JN.

Neurosurgery. 2018 Aug 1;83(2):263-269. doi: 10.1093/neuros/nyx354.

PMID:
28973498
28.

Targeting brain tumors by intra-arterial delivery of cell-penetrating peptides: a novel approach for primary and metastatic brain malignancy.

Joshi S, Cooke JRN, Ellis JA, Emala CW, Bruce JN.

J Neurooncol. 2017 Dec;135(3):497-506. doi: 10.1007/s11060-017-2615-5. Epub 2017 Sep 5.

PMID:
28875440
29.

Subependymomas Are Low-Grade Heterogeneous Glial Neoplasms Defined by Subventricular Zone Lineage Markers.

D'Amico RS, Praver M, Zanazzi GJ, Englander ZK, Sims JS, Samanamud JL, Ogden AT, McCormick PC, Feldstein NA, McKhann GM 2nd, Sisti MB, Canoll P, Bruce JN.

World Neurosurg. 2017 Nov;107:451-463. doi: 10.1016/j.wneu.2017.08.009. Epub 2017 Aug 10.

PMID:
28804038
30.

Comparing sequencing assays and human-machine analyses in actionable genomics for glioblastoma.

Wrzeszczynski KO, Frank MO, Koyama T, Rhrissorrakrai K, Robine N, Utro F, Emde AK, Chen BJ, Arora K, Shah M, Vacic V, Norel R, Bilal E, Bergmann EA, Moore Vogel JL, Bruce JN, Lassman AB, Canoll P, Grommes C, Harvey S, Parida L, Michelini VV, Zody MC, Jobanputra V, Royyuru AK, Darnell RB.

Neurol Genet. 2017 Jul 11;3(4):e164. doi: 10.1212/NXG.0000000000000164. eCollection 2017 Aug.

31.

Breast cancer subtype and stage are prognostic of time from breast cancer diagnosis to brain metastasis development.

Saraf A, Grubb CS, Hwang ME, Tai CH, Wu CC, Jani A, Lapa ME, Andrews JIS, Vanderkelen S, Isaacson SR, Sonabend AM, Sheth SA, McKhann GM, Sisti MB, Bruce JN, Cheng SK, Connolly EP, Wang TJC.

J Neurooncol. 2017 Sep;134(2):453-463. doi: 10.1007/s11060-017-2549-y. Epub 2017 Jul 3.

PMID:
28674973
32.

Sodium Fluorescein Facilitates Guided Sampling of Diagnostic Tumor Tissue in Nonenhancing Gliomas.

Bowden SG, Neira JA, Gill BJA, Ung TH, Englander ZK, Zanazzi G, Chang PD, Samanamud J, Grinband J, Sheth SA, McKhann GM 2nd, Sisti MB, Canoll P, D'Amico RS, Bruce JN.

Neurosurgery. 2018 May 1;82(5):719-727. doi: 10.1093/neuros/nyx271.

PMID:
28645214
33.

Inhibition of Mitochondrial Matrix Chaperones and Antiapoptotic Bcl-2 Family Proteins Empower Antitumor Therapeutic Responses.

Karpel-Massler G, Ishida CT, Bianchetti E, Shu C, Perez-Lorenzo R, Horst B, Banu M, Roth KA, Bruce JN, Canoll P, Altieri DC, Siegelin MD.

Cancer Res. 2017 Jul 1;77(13):3513-3526. doi: 10.1158/0008-5472.CAN-16-3424. Epub 2017 May 18.

34.

Invasiveness is associated with metastasis and decreased survival in hemangiopericytoma of the central nervous system.

Kinslow CJ, Rajpara RS, Wu CC, Bruce SS, Canoll PD, Wang SH, Sonabend AM, Sheth SA, McKhann GM, Sisti MB, Bruce JN, Wang TJC.

J Neurooncol. 2017 Jun;133(2):409-417. doi: 10.1007/s11060-017-2450-8. Epub 2017 Apr 26.

PMID:
28447278
35.

Extent of Resection in Glioma-A Review of the Cutting Edge.

D'Amico RS, Englander ZK, Canoll P, Bruce JN.

World Neurosurg. 2017 Jul;103:538-549. doi: 10.1016/j.wneu.2017.04.041. Epub 2017 Apr 17. Review.

PMID:
28427971
36.

Flow arrest intra-arterial delivery of small TAT-decorated and neutral micelles to gliomas.

Nguyen J, Hossain SS, Cooke JRN, Ellis JA, Deci MB, Emala CW, Bruce JN, Bigio IJ, Straubinger RM, Joshi S.

J Neurooncol. 2017 May;133(1):77-85. doi: 10.1007/s11060-017-2429-5. Epub 2017 Apr 18.

PMID:
28421460
37.

Convection-Enhanced Delivery.

Mehta AM, Sonabend AM, Bruce JN.

Neurotherapeutics. 2017 Apr;14(2):358-371. doi: 10.1007/s13311-017-0520-4. Review.

38.

A Multiparametric Model for Mapping Cellularity in Glioblastoma Using Radiographically Localized Biopsies.

Chang PD, Malone HR, Bowden SG, Chow DS, Gill BJA, Ung TH, Samanamud J, Englander ZK, Sonabend AM, Sheth SA, McKhann GM 2nd, Sisti MB, Schwartz LH, Lignelli A, Grinband J, Bruce JN, Canoll P.

AJNR Am J Neuroradiol. 2017 May;38(5):890-898. doi: 10.3174/ajnr.A5112. Epub 2017 Mar 2.

39.

Autologous Heat Shock Protein Peptide Vaccination for Newly Diagnosed Glioblastoma: Impact of Peripheral PD-L1 Expression on Response to Therapy.

Bloch O, Lim M, Sughrue ME, Komotar RJ, Abrahams JM, O'Rourke DM, D'Ambrosio A, Bruce JN, Parsa AT.

Clin Cancer Res. 2017 Jul 15;23(14):3575-3584. doi: 10.1158/1078-0432.CCR-16-1369. Epub 2017 Feb 13.

40.

The safety of resection for primary central nervous system lymphoma: a single institution retrospective analysis.

Cloney MB, Sonabend AM, Yun J, Yang J, Iwamoto F, Singh S, Bhagat G, Canoll P, Zanazzi G, Bruce JN, Sisti M, Sheth S, Connolly ES, McKhann G.

J Neurooncol. 2017 Mar;132(1):189-197. doi: 10.1007/s11060-016-2358-8. Epub 2017 Jan 23.

41.

Microsurgical resection of pineal region tumors.

Sonabend AM, Bowden S, Bruce JN.

J Neurooncol. 2016 Nov;130(2):351-366. Epub 2016 May 19. Review.

PMID:
27193692
42.

Aggressive resection at the infiltrative margins of glioblastoma facilitated by intraoperative fluorescein guidance.

Neira JA, Ung TH, Sims JS, Malone HR, Chow DS, Samanamud JL, Zanazzi GJ, Guo X, Bowden SG, Zhao B, Sheth SA, McKhann GM 2nd, Sisti MB, Canoll P, D'Amico RS, Bruce JN.

J Neurosurg. 2017 Jul;127(1):111-122. doi: 10.3171/2016.7.JNS16232. Epub 2016 Oct 7.

PMID:
27715437
43.

Safety, feasibility, and optimization of intra-arterial mitoxantrone delivery to gliomas.

Ellis JA, Cooke J, Singh-Moon RP, Wang M, Bruce JN, Emala CW, Bigio IJ, Joshi S.

J Neurooncol. 2016 Dec;130(3):449-454. Epub 2016 Aug 30.

PMID:
27576697
44.

Defining Glioblastoma Resectability Through the Wisdom of the Crowd: A Proof-of-Principle Study.

Sonabend AM, Zacharia BE, Cloney MB, Sonabend A, Showers C, Ebiana V, Nazarian M, Swanson KR, Baldock A, Brem H, Bruce JN, Butler W, Cahill DP, Carter B, Orringer DA, Roberts DW, Sagher O, Sanai N, Schwartz TH, Silbergeld DL, Sisti MB, Thompson RC, Waziri AE, Ghogawala Z, McKhann G 2nd.

Neurosurgery. 2017 Apr 1;80(4):590-601. doi: 10.1227/NEU.0000000000001374. Erratum in: Neurosurgery. 2018 May 1;82(5):749.

45.

Computational pharmacokinetic rationale for intra-arterial delivery to the brain.

Cooke JN, Ellis JA, Hossain S, Nguyen J, Bruce JN, Joshi S.

Drug Deliv Transl Res. 2016 Oct;6(5):622-9. doi: 10.1007/s13346-016-0319-6.

PMID:
27431401
46.

Diversity and divergence of the glioma-infiltrating T-cell receptor repertoire.

Sims JS, Grinshpun B, Feng Y, Ung TH, Neira JA, Samanamud JL, Canoll P, Shen Y, Sims PA, Bruce JN.

Proc Natl Acad Sci U S A. 2016 Jun 21;113(25):E3529-37. doi: 10.1073/pnas.1601012113. Epub 2016 Jun 3.

47.

Quality of Postoperative Venous Thromboembolism Prophylaxis in Neuro-oncologic Surgery.

Zacharia BE, Youngerman BE, Bruce SS, Hershman DL, Neugut AI, Bruce JN, Wright JD.

Neurosurgery. 2017 Jan 1;80(1):73-81. doi: 10.1227/NEU.0000000000001270.

PMID:
27258769
48.

Metabolic reprogramming of glioblastoma cells by L-asparaginase sensitizes for apoptosis in vitro and in vivo.

Karpel-Massler G, Ramani D, Shu C, Halatsch ME, Westhoff MA, Bruce JN, Canoll P, Siegelin MD.

Oncotarget. 2016 Jun 7;7(23):33512-28. doi: 10.18632/oncotarget.9257.

49.

A Synthetic Cell-Penetrating Dominant-Negative ATF5 Peptide Exerts Anticancer Activity against a Broad Spectrum of Treatment-Resistant Cancers.

Karpel-Massler G, Horst BA, Shu C, Chau L, Tsujiuchi T, Bruce JN, Canoll P, Greene LA, Angelastro JM, Siegelin MD.

Clin Cancer Res. 2016 Sep 15;22(18):4698-711. doi: 10.1158/1078-0432.CCR-15-2827. Epub 2016 Apr 28.

50.

Liposome size and charge optimization for intraarterial delivery to gliomas.

Joshi S, Cooke JR, Chan DK, Ellis JA, Hossain SS, Singh-Moon RP, Wang M, Bigio IJ, Bruce JN, Straubinger RM.

Drug Deliv Transl Res. 2016 Jun;6(3):225-33. doi: 10.1007/s13346-016-0294-y.

Supplemental Content

Loading ...
Support Center